CN114105935A - Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction - Google Patents

Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction Download PDF

Info

Publication number
CN114105935A
CN114105935A CN202111467819.5A CN202111467819A CN114105935A CN 114105935 A CN114105935 A CN 114105935A CN 202111467819 A CN202111467819 A CN 202111467819A CN 114105935 A CN114105935 A CN 114105935A
Authority
CN
China
Prior art keywords
nitro
reaction
asymmetric catalytic
carbonyl reduction
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111467819.5A
Other languages
Chinese (zh)
Inventor
费安杰
叶伟平
周章涛
王杨
王道功
罗富元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Raffles Pharmatech Co ltd
Original Assignee
Guangdong Raffles Pharmatech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Raffles Pharmatech Co ltd filed Critical Guangdong Raffles Pharmatech Co ltd
Priority to CN202111467819.5A priority Critical patent/CN114105935A/en
Publication of CN114105935A publication Critical patent/CN114105935A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A method for preparing beta-nitro or azido alcohol by asymmetric catalytic carbonyl reduction with high selectivity comprises the following steps:
Figure DDA0003392262600000011
wherein R is1、R2、R3、R4And R5Each independently selected from any one of H, halogen, nitro, cyano, alkyl, aryl, phenolic hydroxyl and ether; the method of the invention uses RhCl [ (S, S) -TsDPEN]The (p-cymene) asymmetric catalytic reduction of beta-nitro (or azido) ketone can quickly and efficiently construct beta-nitro (or azido) alcohol with high optical activity, and the substrate has wider application range and is suitable for acid-sensitive substrates.

Description

Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction
Technical Field
The invention belongs to the field of preparation of organic matters, and relates to a preparation method of chiral beta-nitro/azido alcohol compounds. In particular, the invention relates to a method for preparing beta-nitro/azido alcohol by asymmetric catalytic carbonyl reduction with high selectivity.
Background
The structural formula of the beta-amino alcohol compound is shown as follows, and the beta-chiral amino alcohol compound is an important organic synthesis intermediate and has an extremely important role in the field of biological pharmacy.
Figure BDA0003392262580000011
The current methods for preparing beta-aminoalcohol compounds mainly include the following schemes: 1) starting from asymmetric Henry reaction, reacting aldehyde substrates with nitroalkane to obtain a beta-nitroalcohol intermediate, and reducing the intermediate through nitro to obtain beta-aminoalcohol; 2) the optically pure beta-nitroalcohol or beta-azido alcohol intermediate is obtained by asymmetrically reducing beta-nitroketone or beta-azido ketone, and the intermediate is reduced by nitryl or azido to obtain beta-amino alcohol.
Figure BDA0003392262580000012
Subject group (Angew. chem. int. Ed.2006,45, 929-931) in Henk Hiemstra, the Netherlands reported an asymmetric Henry reaction catalyzed by a quinine-derived small organic molecule catalyst, the reaction scheme is shown above. Under the condition of 10mol percent of catalyst dosage, the beta-chiral nitroalcohol can be obtained with high yield and high selectivity. However, in order to further enlarge the production, the 10 mol% of the catalyst inventory makes the overall catalyst product higher, the atom economy is poorer, the preparation of the catalyst is relatively complex, the use cost is further promoted, and the method is also the biggest disadvantage of the organic small molecular catalyst in the industrial enlarged production.
Figure BDA0003392262580000021
Subject group (angelw. chem. int. ed.2002,41,861) taught by the american teaching of Barry m.trost reported an asymmetric Henry reaction catalyzed by chiral organozinc, the reaction scheme is shown above. Beta-chiral nitro alcohols can also be prepared with high selectivity. In the reaction process, the catalyst dosage is still high, an equivalent amount of flammable reagent diethyl zinc is needed, and the atom economy is poor; in addition, in order to improve the yield, the dosage of nitromethane also needs 10 equivalents, the reaction conditions are harsh, and the feasibility of industrial amplification is low.
Figure BDA0003392262580000022
The problem group in professor d.a.evans in the united states (j.am.chem.soc.,2003,125,12692) reported that copper catalyzed asymmetric Henry reaction using chiral bisoxazoline as ligand, the reaction scheme is shown above. Although this scheme has a great improvement over the previous reaction conditions and catalyst usage, the 5 mol% equivalent of catalyst is still high and the cost of the chiral ligand is high.
Figure BDA0003392262580000023
Iridium metal catalyzed asymmetric transfer hydrogenation of beta-nitroketones to beta-nitro alcohols was reported by professor Erick m carreira, federal institute of technology, zurich (angelw, chem, int, ed, 2011,50,8979), with the reaction scheme shown above. The scheme has higher efficiency, the dosage of the catalyst is further reduced to a level of five thousandths, and the optical selectivity is higher. However, acid-sensitive substrates cannot be used in this method.
In summary, although various schemes are available at present for preparing chiral β -amino alcohol precursors, further improvements in catalyst efficiency, substrate applicability, etc. are urgently needed.
Disclosure of Invention
In view of the above problems in the prior art, the present invention aims to provide a method for preparing a chiral β -amino alcohol precursor compound to further improve the catalyst efficiency and extend the applicability of the substrate.
Figure BDA0003392262580000031
According to one embodiment of the present invention, the first and second electrodes are, for example,
in the substrate structure: r1、R2、R3、R4And R5Each independently selected from any one of H, halogen, nitro, cyano, alkyl, aryl, phenolic hydroxyl and ether; preferably, R1、R2、R3、R4And R5Each independently selected from any one of H, nitro, methyl, ethyl, benzene ring, phenolic hydroxyl and ether group; r1、R2、R3、R4And R5The reaction center is far away from the periphery of the reaction center, so that the reaction process is not fundamentally influenced, and the selection range is wide.
The desired metal catalyst is RhCl [ (S, S) -TsDPEN ] (p-cymene) (CAS No.192139-90-5), a commercial catalyst, readily available.
The required reducing agent is HCO2H/Et3The N system and triethylamine are matched with formic acid for use, so that the acidity of the formic acid is inhibited, the whole system is neutral to alkalescent, the reducibility of the formic acid can be kept, and the reaction system can still be suitable for acid-sensitive groups; specifically, the methylene carbonyl protecting group of the substrate is sensitive to acid, and if formic acid is directly used as a reducing agent, the methylene carbonyl protecting group can be damaged by the formic acid, and the formic acid-triethylamine system used in the invention can effectively prevent the methylene carbonyl protecting group from being damaged. Preferably, the volume ratio of triethylamine to formic acid is 1.5-2.5: 1, preferably 1.8 to 2.3: 1, further preferably 2.2: 1.
the desired reaction solvent is N, N' -dimethylformamide.
The embodiment of the invention provides a method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction, which comprises the following steps:
Figure BDA0003392262580000041
wherein R is1、R2、R3、R4And R5Each independently selected from any one of H, halogen, nitro, cyano, alkyl, aryl, phenolic hydroxyl and ether;
preferably, R1、R2、R3、R4And R5Each independently selected from any one of H, halogen, nitro, cyano, C1-C18 alkyl, aryl under C20, phenolic hydroxyl and ether under C20;
preferably, R1、R2、R3、R4And R5Each independently selected from H, halogen, nitro, cyano, methyl, ethyl, benzene ring, phenolic hydroxyl and ether groups of C15 or less.
According to one embodiment of the invention, for example, the method is routed as follows:
Figure BDA0003392262580000042
that is, the catalyst is RhCl [ (S, S) -TsDPEN ] (p-cymene), and the structure of the catalyst is shown on the right side of the above route; the reaction takes a mixture of triethylamine and formic acid as a reducing agent.
According to one embodiment of the invention, for example, the molar ratio of triethylamine to substrate 1 is 1-2:1, preferably 1.5-1.8:1, more preferably 1.58: 1;
preferably, the volume ratio of triethylamine to formic acid is 1.5-2.5: 1, preferably 1.8 to 2.3: 1, further preferably 2.2: 1.
according to one embodiment of the invention, for example, the mole percentages of catalyst on substrate 1 are: 0.1 to 0.5 mol%, preferably 0.15 to 0.3 mol%, and more preferably 0.2 mol%.
According to one embodiment of the invention, for example, the reaction is carried out under the protection of inert gas, the reaction is carried out in N, N' -dimethylformamide as a solvent, and the reaction temperature is controlled at 40-60 ℃;
preferably, the molar ratio of N, N' -dimethylformamide to substrate 1 is 100-200:1, preferably 100-150:1, more preferably 128: 1.
According to one embodiment of the invention, for example, the method is routed as follows:
Figure BDA0003392262580000051
according to one embodiment of the invention, for example, the method comprises:
adding a substrate 1 into a reaction container, adding a catalyst RhCl [ (S, S) -TsDPEN ] (p-cymene) under the protection of nitrogen, and then adding N, N' -dimethylformamide; adding triethylamine and formic acid into another reaction vessel, fully mixing and stirring, then adding a mixture of formic acid and triethylamine into the reaction vessel, heating to 50 ℃, and stirring to react for 8-16 hours, preferably 12 hours; after the reaction is finished, diluting the reaction solution with water, then extracting with ethyl acetate, and washing the extracted organic phase with saturated saline solution; and (4) desolventizing under a reduced pressure condition to obtain a target product.
The invention has the beneficial effects that: the scheme adopts RhCl [ (S, S) -TsDPEN ] (p-cymene) to asymmetrically catalyze and reduce beta-nitro (or azido) ketone, can quickly and efficiently construct beta-nitro (or azido) alcohol with high optical activity, has wider substrate application range, and is suitable for acid and alkali sensitive substrates. In particular, when the reduction system is triethylamine-formic acid, reaction substrates with different properties can be matched by adjusting the acid-base property of the system.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description only relate to some embodiments of the present invention and are not limiting on the present invention.
Fig. 1 is a chiral supercritical fluid chromatogram of a racemate of compound 2a prepared in the example.
Fig. 2 is a chiral supercritical fluid chromatogram of compound 2a prepared in the example.
FIG. 3 is a nuclear magnetic hydrogen spectrum of Compound 2a prepared in the example.
Fig. 4 is a chiral supercritical fluid chromatogram of racemate of compound 2b prepared in the example.
Fig. 5 is a chiral supercritical fluid chromatogram of compound 2b prepared in the example.
FIG. 6 is a nuclear magnetic hydrogen spectrum of Compound 2b prepared in the example.
Detailed Description
The method for preparing beta-nitro/azido alcohol by highly selective asymmetric catalytic carbonyl reduction according to the present invention will be further illustrated with reference to the following specific examples. It is to be understood that the following examples are only illustrative and explanatory of the present invention and should not be construed as limiting the scope of the present invention. All the technologies realized based on the above-mentioned contents of the present invention are covered in the protection scope of the present invention.
Example 1
Figure BDA0003392262580000061
Synthesis of chiral beta-nitroalcohols 2a
Weighing substrate 1a (250mg, 1.0mmol) and adding into Schlenk tube, adding catalyst RhCl [ (S, S) -TsDPEN ] under nitrogen protection](p-cymene) (1.3mg, 0.2 mol%) followed by addition of N, N' -dimethylformamide (10 mL). Then triethylamine (0.22mL) and formic acid (0.1mL) were added to another reaction flask and mixed for 3 minutes before the formic acid-triethylamine mixture was added to the schlenk tube. The temperature is raised to 50 ℃, and the reaction is stirred for 12 hours. After completion of the reaction, the reaction mixture was diluted with 50mL of water, followed by extraction with ethyl acetate (30mL × 2), and the extracted organic phase was washed with saturated brine (20mL × 2). Desolventizing under reduced pressure gave the title product 2a, 220mg, 87.3% yield, 96.3% ee. The yield of example 1 according to the invention is close to the highest level compared to the existing synthesis route and the catalyst inventory is minimal compared to the existing synthesis route (the catalyst inventory according to the invention can be as low as 0.2 mol%, whereas the existing route requires at least 0.5 mol%), so it can be said that the catalyst is catalyzedThe efficiency of the agent is improved.1H NMR(400MHz,CDCl3) Delta 7.25(1H, s),7.09-7.10(1H, d),6.95(1H, s),6.77-6.78(1H, d),4.80(2H, s),4.36(1H, s),3.61-3.70(2H, d),1.51(6H, s). The racemate chiral supercritical fluid chromatogram of the target product 2a is shown in the attached figure 1, the chiral supercritical fluid chromatogram is shown in the attached figure 2, and the nuclear magnetic hydrogen chromatogram is shown in the attached figure 3.
Example 2
Figure BDA0003392262580000071
Synthesis of chiral beta-azido alcohols 2b
The substrate 1b (247mg, 1.0mmol) was weighed into a Schlenk tube and the catalyst RhCl [ (S, S) -TsDPEN was added under nitrogen protection](p-cymene) (1.3mg, 0.2 mol%) followed by addition of N, N' -dimethylformamide (10 mL). Then triethylamine (0.22mL) and formic acid (0.1mL) were added to another reaction flask and mixed for 3 minutes before the formic acid-triethylamine mixture was added to the schlenk tube. The temperature is raised to 50 ℃, and the reaction is stirred for 12 hours. After completion of the reaction, the reaction mixture was diluted with 50mL of water, followed by extraction with ethyl acetate (30mL × 2), and the extracted organic phase was washed with saturated brine (20mL × 2). Desolventizing under reduced pressure gave the title product 2b, 225mg, 89.3% yield, 89.9% ee. The yield of example 1 according to the invention is close to the highest level compared to the existing synthesis route, and the catalyst inventory is the lowest compared to the existing synthesis route (the catalyst inventory according to the invention can be as low as 0.2 mol%, whereas the existing route requires at least 0.5 mol%), so it can be said that the catalyst efficiency is improved.1H NMR(400MHz,CDCl3) δ 7.11-7.13(1H, dd),6.99(1H, s),6.79-6.80(1H, d),4.82(1H, s),4.77-4.78(1H, dd),3.37-3.46(2H, m),1.51(6H, s). the racemate chiral supercritical fluid chromatogram of the target product 2b is shown in fig. 4, the chiral supercritical fluid chromatogram is shown in fig. 5, and the nuclear magnetic hydrogen chromatogram is shown in fig. 6.

Claims (7)

1. A method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction is characterized in that the route of the method is as follows:
Figure FDA0003392262570000011
wherein R is1、R2、R3、R4And R5Each independently selected from any one of H, halogen, nitro, cyano, alkyl, aryl, phenolic hydroxyl and ether;
preferably, R1、R2、R3、R4And R5Each independently selected from any one of H, halogen, nitro, cyano, C1-C18 alkyl, aryl under C20, phenolic hydroxyl and ether under C20;
preferably, R1、R2、R3、R4And R5Each independently selected from H, halogen, nitro, cyano, methyl, ethyl, benzene ring, phenolic hydroxyl and ether groups of C15 or less.
2. The method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction according to claim 1, characterized in that the method route is as follows:
Figure FDA0003392262570000012
that is, the catalyst is RhCl [ (S, S) -TsDPEN ] (p-cymene), and the structure of the catalyst is shown on the right side of the above route; the reaction takes a mixture of triethylamine and formic acid as a reducing agent.
3. The method for preparing beta-nitro or azido alcohol by highly selective asymmetric catalytic carbonyl reduction according to claim 1 or 2, characterized in that the molar ratio of triethylamine to substrate 1 is 1-2:1, preferably 1.5-1.8:1, further preferably 1.58: 1;
preferably, the volume ratio of triethylamine to formic acid is 1.5-2.5: 1, preferably 1.8 to 2.3: 1, further preferably 2.2: 1.
4. the method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction according to any of the claims 1 to 3, characterized in that the mole percentage of the catalyst in the substrate 1 is: 0.1 to 0.5 mol%, preferably 0.15 to 0.3 mol%, and more preferably 0.2 mol%.
5. The method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction according to any one of claims 1 to 4, characterized in that, the reaction is carried out under the protection of inert gas, the reaction is carried out in N, N' -dimethylformamide as solvent, and the reaction temperature is controlled at 40-60 ℃;
preferably, the molar ratio of N, N' -dimethylformamide to substrate 1 is 100-200:1, preferably 100-150:1, more preferably 128: 1.
6. The process for preparing beta-nitro or azido alcohol by highly selective asymmetric catalytic carbonyl reduction according to any of the claims 1 to 5, characterized by the following scheme:
Figure FDA0003392262570000021
7. the method for preparing beta-nitro or azido alcohol by highly selective asymmetric catalytic carbonyl reduction according to any of the claims 1 to 6, characterized in that the method comprises:
adding a substrate 1 into a reaction container, adding a catalyst RhCl [ (S, S) -TsDPEN ] (p-cymene) under the protection of nitrogen, and then adding N, N' -dimethylformamide; adding triethylamine and formic acid into another reaction vessel, fully mixing and stirring, then adding a mixture of formic acid and triethylamine into the reaction vessel, heating to 50 ℃, and stirring to react for 8-16 hours, preferably 12 hours; after the reaction is finished, diluting the reaction solution with water, then extracting with ethyl acetate, and washing the extracted organic phase with saturated saline solution; and (4) desolventizing under a reduced pressure condition to obtain a target product.
CN202111467819.5A 2021-12-03 2021-12-03 Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction Pending CN114105935A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111467819.5A CN114105935A (en) 2021-12-03 2021-12-03 Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111467819.5A CN114105935A (en) 2021-12-03 2021-12-03 Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction

Publications (1)

Publication Number Publication Date
CN114105935A true CN114105935A (en) 2022-03-01

Family

ID=80366395

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111467819.5A Pending CN114105935A (en) 2021-12-03 2021-12-03 Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction

Country Status (1)

Country Link
CN (1) CN114105935A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286521A (en) * 2022-07-11 2022-11-04 上海医药集团(本溪)北方药业有限公司 Synthesis method of levosalbutamol hydrochloride

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349502A (en) * 1999-04-01 2002-05-15 旭化成株式会社 Method for the prepn. of tricyclic amino alcohol derivatives through azides
EP1308435A2 (en) * 2001-10-31 2003-05-07 Kanto Kagaku Kabushiki Kaisha Process for producing optically active amino alcohols
US20100009950A1 (en) * 2008-06-30 2010-01-14 Auspex Pharmaceuticals, Inc. Substituted ethanolamines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349502A (en) * 1999-04-01 2002-05-15 旭化成株式会社 Method for the prepn. of tricyclic amino alcohol derivatives through azides
EP1308435A2 (en) * 2001-10-31 2003-05-07 Kanto Kagaku Kabushiki Kaisha Process for producing optically active amino alcohols
US20030171592A1 (en) * 2001-10-31 2003-09-11 Masahito Watanabe Process for producing optically active amino alcohols and intermediates therefore
US20100009950A1 (en) * 2008-06-30 2010-01-14 Auspex Pharmaceuticals, Inc. Substituted ethanolamines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MASAHITO WATANABE 等: "Practical Synthesis of Optically Active Amino Alcohols via Asymmetric Transfer Hydrogenation of Functionalized Aromatic Ketones", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286521A (en) * 2022-07-11 2022-11-04 上海医药集团(本溪)北方药业有限公司 Synthesis method of levosalbutamol hydrochloride
CN115286521B (en) * 2022-07-11 2023-11-03 上海医药集团(本溪)北方药业有限公司 Synthesis method of levosalbutamol hydrochloride

Similar Documents

Publication Publication Date Title
US8859815B2 (en) Sulphonylated diphenylethylenediamines, method for their preparation and use in transfer hydrogenation catalysis
CN114105935A (en) Method for preparing beta-nitro or azido alcohol by high-selectivity asymmetric catalytic carbonyl reduction
CN110294689B (en) Method for preparing nitrile compound by dehydrogenation of primary amine under catalysis of ruthenium metal complex
Hara et al. Mixed La–Li heterobimetallic complexes for tertiary nitroaldol resolution
Li et al. The novel water-soluble chiral PNNP-type ligand for the enantioselective reduction of ketones in aqueous media
CN109622031B (en) Preparation method of 2-hydroxy phosphono zirconium acetate and application thereof in furfuryl alcohol synthesis
CN106187815B (en) A kind of synthetic method of cage compound and application
CN111675736B (en) Rhodium complex containing ortho-carborane Schiff base ligand and preparation method and application thereof
CN102380418B (en) Catalyst for catalyzing and reducing asymmetric prochiral ketones to chiral alcohols, preparation method and application thereof
CN110372514B (en) Method for catalyzing asymmetric Michael addition reaction and catalyst thereof
WO2023097690A1 (en) Method for preparing b-nitro or azido alcohol by means of high-selectivity asymmetric catalytic carbonyl reduction
CN101773856B (en) Oxazoline Schiff base ligand metal complex catalyst and application thereof
CN111087343B (en) Hydroxypyridine ligand, preparation method and catalytic application thereof
WO2009122408A1 (en) STABLE C - (sup3) - CYCLOMETALATED PINCER COMPLEXES, THEIR PREPARATION AND USE AS CATALYSTS
CN110002961A (en) A method of removing racemization synthesis of chiral alcohol
CN115433065B (en) Preparation method of 1, 3-butanediol
CN113929714B (en) Preparation method of chiral benzyl silane compound
JP7439055B2 (en) Continuous preparation of optically active carbonyl compounds by asymmetric hydrogenation
CN116239573B (en) Preparation method and application of metal organic quaternary cyclic compound
Nindakova et al. New C 2-symmetric optically active salen ligands and their cobalt (II) complexes. Hydridoborate reduction of prochiral C= O and C= C bonds
Skarżewski et al. Substituted N-salicylidene β-aminoalcohols: Preparation and use as chiral ligands in enantioselective sulfoxidation and conjugate addition
CN118084977A (en) Multi-ligand molybdenum complex and preparation method and application thereof
Saranya et al. Application as Catalyst
CN117209399A (en) Synthesis method and application of chiral bialkenenitrile compound
CN116462711A (en) Bidentate nitrogen-manganese complex, preparation method thereof, catalyst composition and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20220301

RJ01 Rejection of invention patent application after publication